homepage-top-section Archives - Page 62 of 62 - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

homepage-top-section

- News
July 1, 2018

Roche’s Tecentriq plus chemo meets PFS goal in triple negative breast cancer

By PBR Staff Writer

The chemotherapy used in combination with Tecentriq is Abraxane [albumin-bound paclitaxel; nab-paclitaxel]). The late-stage trial dubbed IMpassion130 was found to have reduced the risk of disease worsening or
News
June 29, 2018

Sanofi, Advent finalize negotiations for acquisition of Zentiva

By admin

The companies announced that they had entered into exclusive talks on April 17, 2018. The signing of this Share Purchase Agreement marks a critical step on the way
News
June 29, 2018

Arsanis to discontinue phase 2 trial of pneumonia drug over futility

By admin

Based on the results of this analysis, the DRC determined that the trial was futile, meaning that it was not likely to meet its primary end-point upon completion